Get the Stockscreener App
1.07
4.04%
-0.045
Standard Biotools Inc stock is traded at $1.07, with a volume of 592.51K.
It is down -4.04% in the last 24 hours and down -7.76% over the past month.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.
See More
Previous Close:
$1.115
Open:
$1.11
24h Volume:
592.51K
Relative Volume:
0.38
Market Cap:
$455.79M
Revenue:
$106.34M
Net Income/Loss:
$-74.66M
P/E Ratio:
-1.1263
EPS:
-0.95
Net Cash Flow:
$-46.12M
1W Performance:
-10.83%
1M Performance:
-7.76%
6M Performance:
-50.23%
1Y Performance:
-55.60%
1-Day Range:
$1.06
$1.135
1-Week Range:
$0.9521
$1.22
52-Week Range:
$0.9521
$2.74
Standard Biotools Inc Stock (LAB) Company Profile
Name
Standard Biotools Inc
Sector
Industry
Phone
(650) 266-6000
Address
2 TOWER PLACE, SOUTH SAN FRANCISCO
Compare LAB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LAB
Standard Biotools Inc
|
1.07 | 455.79M | 106.34M | -74.66M | -46.12M | -0.95 |
|
ABT
Abbott Laboratories
|
133.24 | 231.09B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.86 | 155.24B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
380.92 | 144.54B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.48 | 108.82B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.68 | 44.31B | 5.54B | 4.18B | 623.10M | 7.00 |
Standard Biotools Inc Stock (LAB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-27-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Apr-16-24 | Initiated | TD Cowen | Buy |
| Apr-04-24 | Initiated | Jefferies | Buy |
| Jul-12-23 | Initiated | KeyBanc Capital Markets | Overweight |
Standard Biotools Inc Stock (LAB) Latest News
Standard BioTools outlines $165M-$175M revenue target for FY2025 while driving proteomics partnerships - MSN
Before You Sell Standard BioTools Inc (NASDAQ: LAB) Shares, Here’sWhat You Need To Know. - Stocksregister
Standard BioTools First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
MetLife Investment Management LLC Purchases 40,057 Shares of Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Standard BioTools Inc. Earnings Call: Mixed Outlook Amid Challenges - TipRanks
Standard BioTools Inc. (NASDAQ:LAB) Q1 2025 Earnings Call Transcript - Insider Monkey
Standard BioTools Inc (LAB) Q1 2025 Earnings Call Highlights: Navigating Challenges with ... - Yahoo
Standard BioTools Inc (LAB) Q1 2025 Earnings Call Highlights: Navigating Challenges with ... By GuruFocus - Investing.com Canada
Standard BioTools Inc (LAB) Q1 2025 Earnings Call Highlights: Na - GuruFocus
Standard BioTools: Q1 Earnings Snapshot - CTPost
Standard BioTools Shows Resilience Amid Revenue Decline - TipRanks
Standard BioTools Inc. 2025 Q1ResultsEarnings Call Presentation (NASDAQ:LAB) - Seeking Alpha
Earnings call transcript: Standard Biotools reports Q1 2025 loss, stock dips - Investing.com
Standard BioTools (LAB) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Standard BioTools Q1 2025 Financial Results Overview - TipRanks
Standard BioTools Inc (LAB) Q1 2025 Earnings: EPS of -$0.07 Beats Estimate, Revenue of $40.8M Exceeds Expectations - GuruFocus
Standard BioTools (LAB) Exceeds Q1 Revenue Estimates with Strong Performance | LAB Stock News - GuruFocus
STANDARD BIOTOOLS Earnings Results: $LAB Reports Quarterly Earnings - Nasdaq
Standard BioTools Q1 2025 slides: revenue falls 10% as company advances cost-cutting - Investing.com
Standard BioTools Reports First Quarter 2025 Financial Results - The Manila Times
Market Recap: Standard BioTools Inc (LAB)’s Negative Momentum, Closing at 1.15 - DWinneX
Standard BioTools Q1 2025 Earnings Preview - MSN
Wells Fargo & Company MN Has $317,000 Stock Position in Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Standard BioTools Inc (LAB) Q1 2025 Earnings Report Preview: Wha - GuruFocus
Standard BioTools Inc (LAB) Q1 2025 Earnings Report Preview: What To Look For - GuruFocus
Invesco Ltd. Acquires 12,194 Shares of Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Standard BioTools Inc expected to post a loss of 7 cents a shareEarnings Preview - TradingView
Standard BioTools Inc (LAB) requires closer examination - uspostnews.com
Standard BioTools cut to Neutral at KeyBanc on guidance - MSN
Standard BioTools Inc [LAB] Stock bought by Insider Casdin Partners Master Fund, L for $5.13 million - knoxdaily.com
Legal & General Group Plc Cuts Position in Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Stock Performance Spotlight: Standard BioTools Inc (LAB) Ends the Day at 1.16, Down by -5.69 - DWinneX
Standard BioTools Inc [LAB] Records 50-Day SMA of $1.1772 - knoxdaily.com
Standard BioTools (LAB) Introduces Advanced Proteomic Products a - GuruFocus
Standard BioTools Inc (LAB)’s stock price in review: A technical analysis - uspostnews.com
Standard BioTools Inc (LAB) Stock: Navigating Market Highs and Lows in 52 Weeks - investchronicle.com
Standard BioTools Announces New Product Innovations in Plasma and Single-Cell Proteomics at AACR 2025 - The Manila Times
Standard BioTools Inc. Announces New Product Innovations in Plasma and Single-Cell Proteomics at AACR 2025 - marketscreener.com
Standard BioTools Unveils Game-Changing 3.7K Protein Assay: 4X Faster Analysis Transforms Cancer Research - Stock Titan
Analysts Advise You To Maintain Your Position In Standard BioTools Inc (NASDAQ: LAB) - Stocksregister
Standard BioTools Schedules First Quarter Earnings Conference Call on May 6, 2025 - The Manila Times
Standard BioTools Inc. to Announce First Quarter 2025 Financial Results on May 6, 2025 - Nasdaq
Standard BioTools Earnings Preview: Key Q1 2025 Updates Coming May 6What to Watch - Stock Titan
Standard BioTools Inc. (NASDAQ:LAB) Shares Acquired by Geode Capital Management LLC - Defense World
Positive week for Standard BioTools Inc. (NASDAQ:LAB) institutional investors who lost 58% over the past year - simplywall.st
Vanguard Group Inc. Decreases Stake in Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Standard BioTools Inc. (NASDAQ:LAB) Shares Bought by American Century Companies Inc. - Defense World
Corebridge Financial Inc. Sells 11,070 Shares of Standard BioTools Inc. (NASDAQ:LAB) - Defense World
40,166 Shares in Standard BioTools Inc. (NASDAQ:LAB) Acquired by KLP Kapitalforvaltning AS - Defense World
Major Improvements In Standard BioTools Inc (LAB) Stock Need To Be Considered - stocksregister.com
Commonwealth Equity Services LLC Sells 51,993 Shares of Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Standard Biotools Inc Stock (LAB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.11%
0.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):